Deutsche Bank’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,885
| Closed | -$121K | – | 4115 |
|
|
2022
Q1 | $121K | Sell |
13,885
-1,658
| -11% | -$14.4K | ﹤0.01% | 3475 |
|
|
2021
Q4 | $249K | Buy |
15,543
+780
| +5% | +$12.5K | ﹤0.01% | 3241 |
|
|
2021
Q3 | $272K | Sell |
14,763
-452
| -3% | -$8.33K | ﹤0.01% | 3380 |
|
|
2021
Q2 | $213K | Buy |
15,215
+1,262
| +9% | +$17.7K | ﹤0.01% | 3714 |
|
|
2021
Q1 | $205K | Sell |
13,953
-1,239
| -8% | -$18.2K | ﹤0.01% | 3590 |
|
|
2020
Q4 | $294K | Buy |
15,192
+6,916
| +84% | +$134K | ﹤0.01% | 3200 |
|
|
2020
Q3 | $92K | Buy |
8,276
+752
| +10% | +$8.36K | ﹤0.01% | 3537 |
|
|
2020
Q2 | $102K | Buy |
7,524
+4,055
| +117% | +$55K | ﹤0.01% | 3374 |
|
|
2020
Q1 | $28K | Sell |
3,469
-4,461
| -56% | -$36K | ﹤0.01% | 3713 |
|
|
2019
Q4 | $76K | Buy |
7,930
+5,045
| +175% | +$48.4K | ﹤0.01% | 3640 |
|
|
2019
Q3 | $30K | Sell |
2,885
-4,852
| -63% | -$50.5K | ﹤0.01% | 4017 |
|
|
2019
Q2 | $88K | Sell |
7,737
-2,217
| -22% | -$25.2K | ﹤0.01% | 4125 |
|
|
2019
Q1 | $127K | Sell |
9,954
-1,077
| -10% | -$13.7K | ﹤0.01% | 4089 |
|
|
2018
Q4 | $67K | Sell |
11,031
-8,291
| -43% | -$50.4K | ﹤0.01% | 4171 |
|
|
2018
Q3 | $203K | Buy |
19,322
+6,748
| +54% | +$70.9K | ﹤0.01% | 4126 |
|
|
2018
Q2 | $184K | Buy |
12,574
+4,747
| +61% | +$69.5K | ﹤0.01% | 4191 |
|
|
2018
Q1 | $110K | Sell |
7,827
-5,466
| -41% | -$76.8K | ﹤0.01% | 4280 |
|
|
2017
Q4 | $155K | Buy |
+13,293
| New | +$155K | ﹤0.01% | 3938 |
|